Interventions related to cardiovascular complications in people hospitalized by covid-19: a scoping review

José Hiago Feitosa de Matos1, Emiliana Bezerra Gomes1, Natália Pinheiro Fabricio Formiga1

  • 1Universidade Regional do Cariri. Crato, Ceará, Brazil.

Insights

This review highlights common cardiovascular complications in COVID-19 patients, including myocardial injury. Evidence suggests interventions like oxygen therapy and thrombotic disorder management, but lacks consensus on nursing roles.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • COVID-19, a novel coronavirus infection, has been associated with various systemic complications.
  • Cardiovascular complications represent a significant concern in hospitalized COVID-19 patients.
  • Understanding these complications and necessary interventions is crucial for patient management.

Purpose of the Study:

  • To systematically review the scientific evidence regarding cardiovascular complications in COVID-19 patients.
  • To identify the need for cardiovascular interventions in this population.

Main Methods:

  • A scoping review was conducted following The Joanna Briggs Institute (JBI) methodology.
  • Searches were performed across major databases: MEDLINE, CINAHL, SCOPUS, and Web of Science.

Main Results:

  • Eleven studies published between December 2019 and April 2020 were included, characterized by low levels of evidence.
  • Myocardial injury was the most frequently reported cardiac complication, affecting 8-12% of severe COVID-19 cases.
  • Interventions indicated included oxygen therapy, prevention/treatment of thrombotic disorders, hemodynamic monitoring, cardiac function tests, and biochemical markers, with no specific nursing interventions identified.

Conclusions:

  • The current evidence on cardiovascular complications and interventions in COVID-19 lacks consensus.
  • Further explanatory studies are needed to establish causal relationships.
  • Development of multi-professional clinical protocols is recommended to guide patient care.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
95
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
107
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
242
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
124
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
121
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
475